Mycobacterium bovis BCG mycobacteria - New application

Polish Journal of Microbiology

Volumn 55, Issue 1, 2006, Pages 13-17

  Kowalewicz Kulbat, Magdalena ^a   Pestel, Joël ^b   Biet, Franck ^c   Locht, Camille ^b   Tonnel, André Bernard ^b   Druszczyńska, Magdalena ^a   Rudnicka, Wiesława ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b INSTITUT PASTEUR DE LILLE   (France)

^c CEMAGREF   (France)

Author keywords

BCG; Der p 1 allergen; Th1 Th2 cytokines

Indexed keywords

ALLERGY; ARTICLE; ASTHMA; BCG VACCINATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; HELPER CELL; HOUSE DUST; HUMAN; MITE; MYCOBACTERIUM BOVIS;

ANIMALS; ANTIGENS, DERMATOPHAGOIDES; BCG VACCINE; COCULTURE TECHNIQUES; DENDRITIC CELLS; HUMANS; HYPERSENSITIVITY; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-5; PYROGLYPHIDAE; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TH2 CELLS;

ACARI; ASTIGMATA; CORYNEBACTERINEAE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; PYROGLYPHIDAE;

EID: 33646475885     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Geha R.S. 2003. Allergy and hypersensitivity. Nature versus nurture in allergy and hypersensitivity. Curr. Opin. Immunol. 15: 603-608.
2. Grakoui A., S.K. Bromley, C. Sumen, M.M. Davis, A.S. Shaw, P.M. Allen and M.L. Dustin. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285: 221-227.
3. Griffin J.F., C.G. Mackintosh, L. Slobbe, A.J. Thomson and G.S. Buchan. 1999. Vaccine protocols to optimise the protective efficacy of BCG. Tuber. Lung Dis. 79: 135-143.
4. Herr H.W. 2005. Restaging transurethal resection of high risk superficial bladder cancer improves the initial response to Bacille Calmette-Guérin therapy. J. Urol. 174: 2134-2137.
5. Hoft D.F., C. Leonardi, T. Milligan, G.T. Nahass, B. Kemp, S. Cook, J. Tennant and M. Carey. 1999. Clinical reactogenicity of intradermal Bacille Calmette-Guérin vaccination. Clin. Infect. Dis. 28: 785-790.
6. Huebner R.E. 1996. BCG vaccination in the control of tuberculosis. Curr. Top. Microbiol. Immunol. 215: 263-282.
7. Jacobe Hi J., P. G. Andres, J. Boisvert and M.F. Krummel. 2004. New views of the immunological synapse: variations in asembly and function. Curr. Opin. Immunol. 16: 345-352.
8. Kaufmann S.H.E. 2005. Rational vaccine design against tuberculosis. Vaccine Congress. New Approches to Vaccine Development. From the bench to the field. 8-10 September 2005, Berlin, Germany.
9. Lallemant-LeCoeur S., M. Lallemant, D. Cheynier, S. Nzingoula, J. Drucker and B. Larouze. 1991. Bacillus Calmette-Guérin immunization in infants born to HIV-1-seropositive mothers. AIDS 5: 195-199.
10. Lambrecht B.N. and H. Hammad. 2003. The other cells in asthma: dendritic cell and epithelial cell crosstalk. Curr. Opin. Pulm. Med. 9: 34-41.
11. Marchant A., T. Goetghebuer, O. MO, I. Wolfe, S.J. Ceesay, D. De Groote, T. Corrah, S. Bennett, J. Wheeler, K. Huygen, P. Aaby, K.P. McAdam and M. Newport. 1999. Newborns develop a Th1-type immune response to Mycobacterium bovis Bacillus Calmette-Guérin vaccination. J. Immunol. 163: 2249-2255.
12. Pochard P., H. Hammad, C. Ratajczak, A-S. Charbonnier-Hatzfeld, N. Just, A-B. Tonnel and J. Pestel. 2005. Direct regulatory immune activity of lactic acid bacteria on Der p-1 pulsed dendritic cells from allergic patients. J. Allergy Clin. Immunol. 116: 198-204.
13. Romagnani S. 2000. The role of lymphocytes in allergic disease. J. Allergy Clin. Immunol. 105: 399-408.
14. Williams A., A. Davies, P.D. Marsh, M.A. Chambers and R.G. Hewinson. 2000. Comparison of the protective efficacy of Bacille Calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis. Clin. Infect. Dis. 30, Suppl. 3: S299-301.